Cambridge, Massachusetts
United States
32
2020-12-17
20
2022-08-16
These are the the leading inventors for applications assigned to BOSTON BIOMEDICAL, INC.:
BOSTON BIOMEDICAL, INC. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Process for producing a hydrate of a hydrochloride salt of 2,2′-((((((2-acetylnaphtho[2,3-b]furan-4,9-diyl)bis(oxy))bis(carbonyl))bis(azanediyl))bis(ethane-2,1-diyl))bis(azanediyl))diacetic acid
#2 | 2019-12-26 ✅ Patent 10,543,189 granted on 2020-01-282-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer
#3 | 2019-08-08 ✅ Patent 10,683,274 granted on 2020-06-163-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
#4 | 2019-05-09 ✅ Patent 10,377,731 granted on 2019-08-13Compositions and methods for cancer treatment
#5 | 2019-03-21 ✅ Patent 10,800,752 granted on 2020-10-13Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
#6 | 2018-11-22 ✅ Patent 10,646,464 granted on 2020-05-12Methods for treating cancer
#7 | 2018-09-06METHOD FOR TREATING CANCER WITH A STAT3 PATHWAY INHIBITOR AND KINASE INHIBITOR
#8 | 2018-09-06METHODS FOR TREATING CANCER
#9 | 2018-07-12NOVEL METHODS FOR TREATING CANCER
#10 | 2018-04-26 ✅ Patent 10,183,925 granted on 2019-01-22Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
#11 | 2018-04-12METHODS FOR TREATING CANCER
#12 | 2018-03-29METHODS FOR TREATING CANCER
#13 | 2018-02-01NOVEL GROUP OF STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL PATHWAY INHIBITORS
#14 | 2018-02-01NOVEL COMPOSITIONS AND METHODS FOR CANCER TREATMENT
#15 | 2017-11-09NOVEL METHODS FOR TARGETING CANCER STEM CELLS
#16 | 2017-06-22 ✅ Patent 10,017,488 granted on 2018-07-103-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereof
#17 | 2017-01-19ASYMMETRIC INTERFERING RNA COMPOSITIONS THAT SILENCE K-RAS AND METHODS OF USES THEREOF
#18 | 2017-01-19NEW TRICYCLIC QUINONE DERIVATIVE
#19 | 2016-11-24 ✅ Patent 9,795,595 granted on 2017-10-24Methods for treating cancer
#20 | 2016-02-043-(ARYL OR HETEROARYL) METHYLENEINDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF CANCER STEM CELL PATHWAY KINASES FOR THE TREATMENT OF CANCER
#21 | 2016-02-042-ACETYLNAPHTHO[2,3-B]FURAN -4,9-DIONE FOR USE ON TREATING CANCER
#22 | 2015-07-16 ✅ Patent 9,725,444 granted on 2017-08-08Compositions of kinase inhibitors and their use for treatment of cancer and other diseases related to kinases
#23 | 2015-07-02 ✅ Patent 9,381,184 granted on 2016-07-05Compounds and compositions for targeting cancer stem cells
#24 | 2015-01-15 ✅ Patent 9,834,532 granted on 2017-12-05Stat3 pathway inhibitors and cancer stem cell inhibitors
#25 | 2014-09-18 ✅ Patent 9,227,962 granted on 2016-01-05Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative
#26 | 2014-09-18 ✅ Patent 9,187,454 granted on 2015-11-17Inhibitors of kinases and cancer stem cells, and methods of preparation and use thereof
#27 | 2013-12-12 ✅ Patent 9,481,884 granted on 2016-11-01Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells
#28 | 2013-02-07 ✅ Patent 9,084,766 granted on 2015-07-21Compounds and compositions for targeting cancer stem cells
#29 | 2013-01-31 ✅ Patent 9,730,909 granted on 2017-08-15Methods for targeting cancer stem cells
#30 | 2012-10-04 ✅ Patent 9,745,278 granted on 2017-08-29Group of STAT3 pathway inhibitors and cancer stem cell pathway inhibitors
#31 | 2011-05-12 ✅ Patent 8,877,803 granted on 2014-11-04Stat3 pathway inhibitors and cancer stem cell inhibitors
#32 | 2010-12-09 ✅ Patent 9,732,055 granted on 2017-08-15Compositions and methods for cancer treatment
Also check out Boston Biomedical, Inc.'s (Cambridge, United States) applicant profile with 13 patent applications submitted.
48522 ⎘